Cargando…
Cancer and Thrombotic Risk: The Platelet Paradigm
Hematologic malignancies and solid tumors increase the risk of venous and arterial thrombosis and contribute greatly to patient morbidity and mortality. Thrombosis occurs when the intricate balance of circulating antithrombotic and prothrombotic blood elements are disrupted. In recent years, the int...
Autores principales: | Lee, Elizabeth C., Cameron, Scott J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682001/ https://www.ncbi.nlm.nih.gov/pubmed/29164134 http://dx.doi.org/10.3389/fcvm.2017.00067 |
Ejemplares similares
-
Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications
por: Schrottmaier, Waltraud C., et al.
Publicado: (2022) -
Case Report: Hypergranular Platelets in Vaccine-Induced Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination
por: Comer, Shane P., et al.
Publicado: (2022) -
FcγRIIa - dependent platelet activation identified in COVID-19 vaccine-induced immune thrombotic thrombocytopenia-, heparin-induced thrombocytopenia, streptokinase- and anisoylated plasminogen-streptokinase activator complex-induced platelet activation
por: Abdelouahed, Mustapha, et al.
Publicado: (2023) -
The role of monocytes in thrombotic diseases: a review
por: Han, Zhongyu, et al.
Publicado: (2023) -
Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
por: Aday, Aaron W., et al.
Publicado: (2019)